SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual ...
The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Ocugen OCGN is pushing a modifier gene therapy platform across several retinal diseases where current options are limited, ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment, causing epilepsy, intellectual disability, psychomotor delay and, frequently, autism.
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
On 25 April 1953, Watson and Crick published an article, in the acclaimed journal “Nature” titled “Molecular structure of nucleic acids: A structure for deoxyribonucleic acid”. The one-page article ...
Health and Me on MSN
World DNA Day: Are Indians more prone to early onset of lifestyle diseases?
This DNA Day, let us understand that genetics is not destiny, but it does set the stage.
Gene regulation timing, controlled by non-coding DNA elements, drives limb development, with disruptions leading to distinct ...
Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...
By comparing genetic data from 23 million newborns to rare disease models, researchers found some models’ estimates were 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results